clinical hold

pause halt pause button
Biotech

Daiichi-Merck ph. 3 ADC program on pause after patient deaths

Daiichi and Merck’s phase 3 program for I-DXd has been hit with a hold after an unexpected number of deaths occurred.
Gabrielle Masson Dec 18, 2025 11:22am
yellow traffic light

Denali ph. 1 Pompe plans hit with clinical hold

Dec 4, 2025 11:52am
FDA stop sign

FDA puts Tenaya heart disease gene therapy trial on hold

Nov 10, 2025 5:16am
Stop sign

FDA puts Intellia CRISPR trials on hold over raised liver enzyme

Oct 30, 2025 6:37am
space launch rocketship

Rocket's gene therapy free from FDA hold

Aug 20, 2025 10:40am
delay FDA delay

Another biotech hit with FDA delay for ALS asset

Aug 18, 2025 11:01am